武汉大学人民医院湖北省人民医院

院内导航

胡知朋 心胸外
科副主任，副教授、副主任医师、硕士研究生导师

A+ A-

导师介绍

姓名	胡知朋
出生年月	1981年9月
单位	武汉大学人民医院心血管外科
所属学科	临床医学-外科学
职务、职称及头衔	科副主任，副教授、副主任医师、硕士研究生导师
E-mail	zp.hu@foxmail.com
联系方式	027-88041911转82239
研究方向	1.微创心血管外科 2.心血管疾病的代谢基础
个人简介	从事心血管外科临床和科研，常规开展全胸腔镜心脏手术、小切口胸腔镜辅助心脏手术、免开刀瓣膜介入手术、先天性心脏病介入封堵手术、大血管疾病介入手术；聚焦大血管疾病的代谢基础研究，第一作者\通讯作者发表SCI论文14篇；主持国家自然科学基金、湖北省自然科学基金、中华国际医学交流基金、武汉大学人民医院青年重点人才基金、武汉大学医学教育项目各一项；设计的主动脉弓部支架获得国家专利。
学术任职与荣誉	湖北省医师协会心血管外科医师分会委员；湖北省欧美同学会(留学生联会)青年委员；湖北省医疗事故鉴定专家；武汉大学人民医院青年重点人才；教育部学位论文评审专家；湖北省科技评审专家、ANN Transplan等15本SCI收录医学期刊特约审稿人
教育履历	2001.09-2006.06华中科技大学同济医学院临床医学专业本科生获学士学位 2009.09-2011.12华中科技大学同济医学院协和医院心血管外科硕士研究生获硕士学位 2012.09-2015.12武汉大学第一临床学院心血管外科学博士研究生获博士学位 2014.8-2014.11哈佛医学院联合培养博士生 2014.11-2015.8宾夕法尼亚大学医学院联合培养博士生
工作履历	2015.9-2016.12武汉大学人民医院心血管外科主治医师 2016.12至今武汉大学人民医院心血管外科副主任医师 2020.12至今武汉大学人民医院心血管外科副教授 2022.5至今武汉大学人民医院心血管外科副主任
成果获奖	1.《主动脉疾病发病基础及复杂升弓部大血管手术技术创新》2015年湖北省科技进步一等奖，2016武汉市科技进步一等奖（12/15）
代表性论著	1.Hu Z, Li B, Wang Z, Hu X, Zhang M, Chen R, Wu Q, Jia F. The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFbeta by suppressing the expression of the TGFbeta receptor ALK5 in aorta remodeling. Mol Med Rep. 2020;22(1):387-97. 2.Hu Z, Wang Z, Chang J, Zhang M, Hu X, Ren Z, Li B, Hu R. Application of prosthesis eversion method for ascending aorta replacement guarantees better clinical outcomes of type A acute aortic dissection surgery. J Thorac Dis. 2021;13(2):533-40. 3.Hu Z, Wang Z, Min X, Li B, Zhang M, Dai F, Cai X. Successful short interval staged surgery in synchronous type A aortic dissection and giant abdominal aortic aneurysm patient. Heliyon. 2022;8(10):e10964. 4.Zhang M, Jian L, Min X, Li B, Cai X, Wang Z,Hu Z*. Perioperative Fluoroquinolone Treatment Deteriorates Prognosis Following Coronary Artery Bypass Grafting. J Cardiovasc Dev Dis. 2022;9(6). 5.Wu QI#,Hu Z#, Wang Z, Che Y, Zhang M, Zheng S, Xing K, Zhong X, Chen Y, Shi F, Yuan S. Glut10 restrains neointima formation by promoting SMCs mtDNA demethylation and improving mitochondrial function. Transl Res. 2023.

Name	Zhipeng Hu
Date of birth	Septemper, 1981
Department	Cardiovascular Surgery，Renmin Hospital,Wuhan University.
Title	Associate professer
Email	zp.hu@foxmail.com
TEL	027-88041911-82239
Research Direction	1. Mini invasive cardiac surgery 2. Metabolic baisis of aorta diseases
Personal Profile	Dr Hu Zhipeng is engaged in clinical and scientific research of cardiovascular surgery, routinely carrying out total thoracoscopic cardiac surgery, small incision thoracoscopic assisted cardiac surgery, valvular interventional surgery, congenital heart disease intervention, and macrovascular intervention. He focuses on the metabolic mechanism of macrovascular diseases. He published 14 SCI manuscripts. He has been funded by the National Natural Science Foundation, Hubei Natural Science Foundation, China International Medical Exchange Fund, Wuhan University people's Hospital Youth key Talent Fund, Wuhan University medical education project. An aortic arch stent designed by Dr Hu won the national patent.
Selected Publications	1.Hu Z, Li B, Wang Z, Hu X, Zhang M, Chen R, Wu Q, Jia F. The sympathetic transmitter norepinephrine inhibits VSMC proliferation induced by TGFbeta by suppressing the expression of the TGFbeta receptor ALK5 in aorta remodeling. Mol Med Rep. 2020;22(1):387-97. 2.Hu Z, Wang Z, Chang J, Zhang M, Hu X, Ren Z, Li B, Hu R. Application of prosthesis eversion method for ascending aorta replacement guarantees better clinical outcomes of type A acute aortic dissection surgery. J Thorac Dis. 2021;13(2):533-40. 3.Hu Z, Wang Z, Min X, Li B, Zhang M, Dai F, Cai X. Successful short interval staged surgery in synchronous type A aortic dissection and giant abdominal aortic aneurysm patient. Heliyon. 2022;8(10):e10964. 4.Zhang M, Jian L, Min X, Li B, Cai X, Wang Z,Hu Z*. Perioperative Fluoroquinolone Treatment Deteriorates Prognosis Following Coronary Artery Bypass Grafting. J Cardiovasc Dev Dis. 2022;9(6). 5.Wu QI#,Hu Z#, Wang Z, Che Y, Zhang M, Zheng S, Xing K, Zhong X, Chen Y, Shi F, Yuan S. Glut10 restrains neointima formation by promoting SMCs mtDNA demethylation and improving mitochondrial function. Transl Res. 2023.